Email Us
View Reports

Glaucoma Therapeutics Market

Glaucoma Therapeutics Market Analysis - By Disease Type (Primary Open Angle Glaucoma, Primary Angle Closure Glaucoma), By Drug Class (Alpha-adrenergic Agonist, Beta Blockers, Prostaglandin Analogs, Carbonic Anhydrase Inhibitor,Cholinergic, Combined Medication, Fixed-dose Combinations), By EndUser (Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers, Others), By EndUser (Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers, Others), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East &Africa) - Industry Size, Share, Trends, Growth and Global Forecast to 2026

  • ID : 28226681  |  
  • Published : Apr-2019  |  
  • Region : Global  |  
  • Pages : 140   |  
  • Publisher : Research Cosmos

Glaucoma Therapeutics Market Size and Growth Rate:

According to the Research Report, the Global Glaucoma Therapeutics Market Size was valued at USD 5,932.6 Million in 2017 and is expected to reach USD 7,659.8 Million by 2026, with a CAGR of 2.9% from 2018 to 2026.

Glaucoma Therapeutics Market Overview:

Glaucoma is a disease that damages the optic nerve and its progression could cause loss of vision and blindness. Glaucoma treatment begins with topical eye drops in the prostaglandin classes, beta blockers, alpha agonists, combination medications, carbonic anhydrase inhibitors, and cholinergic acid. The administration of these eye drops reduces the production of fluid in the eyes, thus decreasing the intraocular pressure. Topical eye drops are an alternative for surgery or to delay the surgical procedure.

Glaucoma Therapeutics Market Drivers and Restraints:

Higher prevalence and incidence of diabetic disorders, the increase in the geriatric population, the improvement of medical care and the medical care infrastructure, the introduction of combination therapies and the proliferation of awareness programs can stimulate the world market of glaucoma treatments during the prognosis period. It is expected that lack of knowledge of eye disorders, treatment failure, side effects of glaucoma medications and growth in the generic market will limit the market in the near future.

However, emerging economies such as India, China, Brazil, Russia, Mexico, and South Africa offer huge opportunities in the glaucoma treatment market. This is attributed to a large number of unattended patients, the increasing proportion of the urban population and insurance policies. In addition, the governments of the countries mentioned have taken initiatives to raise awareness about glaucoma and its treatment.

Geographical Segmentation of the Glaucoma Therapeutics Market:

Geographically, the global market for glaucoma therapeutics has been segmented into North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa. North America and Europe accounted for a combined market share of 50.2% in 2017. It is expected that North America will continue to dominate the market during the forecast period due to the growth of the geriatric population, increased public awareness of glaucoma, availability of reimbursement and a well-established health care infrastructure.

The Asia-Pacific market is expected to experience a high CAGR growth rate during the forecast period. However, the market in Latin America, the Middle East, and Africa is expected to experience slow growth during the forecast period. Federal governments are placing more emphasis on improving health care facilities and raising awareness among the population are the factors that, contribute to market growth in these regions.

Some of the Promising Companies leading the Global Glaucoma Therapeutics Market Profiled in the Report are:

  • Allergan Inc.,
  • Merck & Co.,
  • Pfizer Inc.,
  • Novartis AG.,
  • Santen Pharmaceuticals
  • Valeant Pharmaceuticals
  • Aerie Pharmaceuticals

The Research Report segments the Glaucoma Therapeutics Market into the following submarkets:

Glaucoma Therapeutics Market – By Disease Type:

  • Primary Open Angle Glaucoma
  • Primary Angle Closure Glaucoma

Glaucoma Therapeutics Market – By Drug Class:

  • Alpha-adrenergic Agonist
  • Beta Blockers
  • Prostaglandin Analogs
  • Carbonic Anhydrase Inhibitor
  • Cholinergic
  • Combined Medication
  • Fixed-dose Combinations

Glaucoma Therapeutics Market – By EndUser:

  • Hospitals
  • Ophthalmic Clinics
  • Ambulatory Surgical Centers
  • Others

Glaucoma Therapeutics Market – By Region:

  • North America

    • United States                                
    • Canada                                          

  • Europe                                                                                  

    • United Kingdom                                            
    • Germany                                       
    • France                                           
    • Italy                                
    • Spain                                             

  • Asia-Pacific                                                     

    • China                                             
    • India                                              
    • Japan                                             
    • South Korea                                  

  • Latin America                                                                             

    • Brazil                                             
    • Argentina                                      
    • Mexico                                          

  • Middle-East & Africa                                                       

    • Middle-East                                  
    • Africa       

Key Takeaways from the Glaucoma Therapeutics Market Report:

  • For different Devices types, and applications offers calculated growth rates (CAGR %), Volume (Units), and Value ($M) in each region to estimate Glaucoma Therapeutics Market potential.
  • Identify various driving factors, constraints and untold opportunities that can impact the Glaucoma Therapeutics Market place
  • Know the position of your competitor based on the market shares, financial performance, strategical approaches, SWOT, product benchmarking and so on.
  • Increase overall revenue by understanding the geographical impact on sales and distribution channels.
  • Evaluate the increase in values at each step of the industry supply chain to improve process efficacy and optimize the value.
  • Understand the market dynamics of leading players like deals, partnerships, new products, mergers and acquisitions in the last four years.
  • Estimate the gaps in supply-demand, statics involved in import-export, and regulatory framework of the Glaucoma Therapeutics Market in over 20 top nations.

**The report can be customized as per your requirements, please write your requirements to sales@researchcosmos.com and we will try to revert at the possible earliest.

Table of Contents:

  1. Introduction                                                                      
  2. Research Methodology                                                                   

    1. Analysis Design                                             

      1. Research Phases                                                            
      2. Secondary Research                                  
      3. Primary Research                                      
      4. Expert Validation                                       

    2. Study Timeline                                                

  3. Overview                                                                         

    1. Executive Summary                                                      
    2. Key Inferences                                                
    3. New Developments                                                      

  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                             

    1. Glaucoma Therapeutics Market  Drivers                      
    2. Glaucoma Therapeutics Market  Restraints                                                         
    3. Key Challenges                                               
    4. Current Opportunities in the Glaucoma Therapeutics Market

  5. Glaucoma Therapeutics Market   Segmentation                                                                    

    1. By Type:

      1. Primary Open Angle Glaucoma
      2. Primary Angle Closure Glaucoma

    2. By Drug Class:

      1. Alpha adrenergic Agonist
      2. Beta Blockers
      3. Prostaglandin Analogs
      4. Carbonic Anhydrase Inhibitor
      5. Cholinergic
      6. Combined Medication
      7. Fixed-dose Combinations

    3. By EndUser

      1. Hospitals
      2. Ophthalmic Clinics
      3. Ambulatory Surgical Centers
      4. Others

  6. Geographical Analysis 

    1. North America Glaucoma Therapeutics Market  

      1. United States                                
      2. Canada                                          

    2. Europe  Glaucoma Therapeutics Market                                                           

      1. United Kingdom                                            
      2. Germany                                       
      3. France                                           
      4. Italy                                
      5. Spain                                             

    3. Asia-Pacific  Glaucoma Therapeutics Market                           

      1. China                                             
      2. India                                              
      3. Japan                                             
      4. South Korea                                  

    4. Latin America Glaucoma Therapeutics Market                   

      1. Brazil                                             
      2. Argentina                                      
      3. Mexico                                          

    5. Middle-East & Africa  Glaucoma Therapeutics Market                                      

      1. Middle-East                                  
      2. Africa                                                                

  7. Strategic Analysis                                                            

    1. PESTLE analysis                                             

      1. Political                                     
      2. Economic                                   
      3. Social                                          
      4. Technological                             
      5. Legal                                          
      6. Environmental                                            

    2. Porter’s five analysis                                                    

      1. Bargaining Power of Suppliers                                  
      2. Bargaining Power of Consumers                               
      3. Threat of New Entrants                             
      4. Threat of Substitute Products and Services                               
      5. Competitive Rivalry within the Industry          

    3. Supply Chain Analysis

      1. Raw Material Suppliers
      2. Manufacturers/Producers
      3. Distributors/Retailers/Wholesalers/E-Commerce
      4. End Users

  8. Glaucoma Therapeutics Market Leaders' Analysis      

    1. Allergan Inc.,

      1. Product Analysis                                        
      2. Strategic Evaluation and Operations                                          
      3. Financial analysis                                         
      4. Legal issues                                
      5. Recent Developments                               
      6. SWOT analysis                                           
      7. Analyst View      

    2. Merck & Co.,
    3. Pfizer Inc.,
    4. Novartis AG.,
    5. Santen Pharmaceuticals
    6. Valeant Pharmaceuticals
    7. Aerie Pharmaceuticals

  9. Competitive Landscape                                                                   

    1. Glaucoma Therapeutics Market  share analysis                                                    
    2. Merger and Acquisition Analysis                                                  
    3. Agreements, collaborations and Joint Ventures                                                       
    4. New Product Launches                                                  

  10. Expert Opinions                                                            

    1. Glaucoma Therapeutics Market  Outlook                                                             
    2. Investment Opportunities                                                           

  11. Appendix                                                             

    1. List of Tables                          
    2. List of Figures

Purchase this Market Research Report

REACH OUT TO US

Call us on : +1 888 709 8757

Drop us an email at : info@researchcosmos.com

HAVE A QUESTION?